Structural basis for the action of the drug trametinib at KSR-bound MEKZ.M. Khan, Arvin C. Dar, Alexander M. Real et al.|Nature|2020Cited by 172
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Kyna Reyes et al.|Nature Cancer|2023Cited by 27
Type II Binders Targeting the “GLR-Out” Conformation of the Pseudokinase STRADαRyan H. B. Smith, Arvin C. Dar, Peter M.U. Ung et al.|Biochemistry|2021Cited by 7
Live-cell target engagement of allosteric MEKi on MEK–RAF/KSR–14-3-3 complexesWilliam M. Marsiglia, Arvin C. Dar, Arthur Chow et al.|Nature Chemical Biology|2023Cited by 5
Conformational control and regulation of the pseudokinase KSR via small molecule binding interactionsArthur Chow, Arvin C. Dar, Z.M. Khan et al.|Methods in enzymology on CD-ROM/Methods in enzymology|2022Cited by 2